The role of cellular genes in West Nile virus (WNV) replication is not well understood. Examination of cellular transcripts upregulated during WNV infection revealed an increase in the expression of the src family kinase (SFK) c-Yes. WNV-infected cell lines treated with the SFK inhibitor PP2 demonstrated a 2-to 4-log decrease in viral titers, suggesting that SFK activity is required for completion of the viral replication cycle. RNA interference mediated knock-down of c-Yes, but not c-Src, and similarly reduced virus yield, specifically implicating c-Yes in WNV production. Interestingly, PP2 treatment did not reduce intracellular levels of either viral RNA or protein, suggesting that the drug does not act on the early stages of replication. However, endoglycosidase H (endoH) digestion of the viral envelope (E) glycoprotein revealed that the acquisition of endoH-resistant glycans by E, but not endogenous major histocompatibility complex class I, was reduced in PP2-treated cells, demonstrating that E specifically does not traffic beyond the endoplasmic reticulum in the absence of SFK activity. Electron microscopy further revealed that PP2-treated WNV-infected cells accumulated an increased number of virions in the ER compared to untreated cells. Therefore, we conclude that inhibition of SFK activity did not interfere with virus assembly but prevented transit of virions through the secretory pathway. These results identify c-Yes as a cellular protein that is involved in WNV assembly and egress.West Nile virus (WNV) is a newly emerging pathogen that has become a significant threat to the U.S. population. First detected in Uganda in 1937, the virus appeared in the United States in the summer of 1999, and since that time it has reemerged each year over an increasing geographical area (1). Typical of flaviviruses, WNV contains a single-stranded positive-sense 11-kb RNA genome. The genome is translated into a single polyprotein, which is cleaved by host and virus-encoded proteases into 10 functional subunits (5, 20). The WNV particle is composed of the subunits derived from the amino terminus of the polyprotein: capsid (C), precursor membrane/ membrane (prM/M), and envelope (E). The remaining seven proteins are nonstructural and function in virus replication. WNV infection results in proliferation and reorganization of intracellular membranes into several unique structures that colocalize with specific subsets of viral proteins, suggesting a distinct spatial segregation of the stages of virus replication (24, 48).WNV virion assembly appears to occur at the rough endoplasmic reticulum (ER), presumably by budding of the nucleocapsid (NC) into the ER lumen (5,20,28). In the context of viral infection, packaging of the genomic RNA requires NS2A and the replication of the RNA by the viral RNA-dependent RNA polymerase NS5 (16,21). The mechanism of NC budding into the ER and acquisition of the viral membrane and glycoproteins is unknown, although a hydrophobic region in the C protein has been proposed to be important in these ...